Cargando…

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects

Hereditary amyloid transthyretin (ATTRv) amyloidosis with polyneuropathy is a progressive disease that is transmitted as an autosomal dominant trait and characterized by multiple organ failure, including axonal sensory-motor neuropathy, cardiac involvement, and autonomic dysfunction. Liver transplan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Massimo, Gentile, Luca, Toscano, Antonio, Aguennouz, M’Hammed, Vita, Giuseppe, Mazzeo, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763612/ https://www.ncbi.nlm.nih.gov/pubmed/33316911 http://dx.doi.org/10.3390/brainsci10120952

Ejemplares similares

Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area
por: Russo, Massimo, et al.
Publicado: (2021)

Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis
por: Vita, Gian Luca, et al.
Publicado: (2020)

Rare among Rare: Phenotypes of Uncommon CMT Genotypes
por: Gentile, Luca, et al.
Publicado: (2021)

Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy
por: Magliano, Lorenza, et al.
Publicado: (2021)

Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy
por: Di Stefano, Vincenzo, et al.
Publicado: (2023)

Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis
por: Plantone, Domenico, et al.
Publicado: (2023)

The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
por: Vera-Llonch, Montserrat, et al.
Publicado: (2021)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)

Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy
por: Dardiotis, Efthimios, et al.
Publicado: (2023)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
por: Gentile, Luca, et al.
Publicado: (2021)

Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features
por: Pozsonyi, Zoltán, et al.
Publicado: (2021)

Ocular findings in patients with acquired ATTRv amyloidosis following domino liver transplantation
por: Kitahara, Junya, et al.
Publicado: (2023)

Focused Ultrasound in Neuroscience. State of the Art and Future Perspectives
por: Giammalva, Giuseppe Roberto, et al.
Publicado: (2021)

Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy
por: Gentile, Luca, et al.
Publicado: (2021)

A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy
por: Vita, Gian Luca, et al.
Publicado: (2021)

Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
por: Cisneros-Barroso, E., et al.
Publicado: (2023)

The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
por: Reddy, Sheila R., et al.
Publicado: (2020)

Hippo signaling pathway is altered in Duchenne muscular dystrophy
por: Vita, Gian Luca, et al.
Publicado: (2018)

TTR-FAP: a single-center experience in Sicily, an Italian endemic area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Strength
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

Physical Activity Intensity Measurement and Health: State of the Art and Future Directions for Scientific Research
por: Rey-López, Juan Pablo, et al.
Publicado: (2023)

Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients
por: Bianchi, Laura, et al.
Publicado: (2021)

A Review of Sustainability Enhancements in the Beef Value Chain: State-of-the-Art and Recommendations for Future Improvements
por: Maia de Souza, Danielle, et al.
Publicado: (2017)

Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
por: Coelho, Teresa, et al.
Publicado: (2022)

A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis
por: Casasnovas, Carlos, et al.
Publicado: (2023)

Role of Inflammation and Oxidative Stress Mediators in Gliomas
por: Conti, Alfredo, et al.
Publicado: (2010)

Prevalence estimation of ATTRv in China based on genetic databases
por: Yongsheng, Zheng, et al.
Publicado: (2023)

Amyloidosis and Longevity: A Lesson from Plants
por: Surguchov, Andrei, et al.
Publicado: (2019)

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022)

Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers
por: Luigetti, Marco, et al.
Publicado: (2022)

Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
por: Di Bella, Gianluca, et al.
Publicado: (2015)

Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years
por: Gentile, L., et al.
Publicado: (2020)

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
por: Wechalekar, Ashutosh D., et al.
Publicado: (2022)

The Role of the Orbitofrontal and Dorsolateral Prefrontal Cortices in Aesthetic Preference for Art
por: Ticini, Luca F.
Publicado: (2017)

State of the Art of Cardiac Amyloidosis
por: Belfeki, Nabil, et al.
Publicado: (2023)

Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage
por: Shen, Junhui, et al.
Publicado: (2022)

ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country
por: Luigetti, Marco, et al.
Publicado: (2021)

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
por: Mahfoud, Felix, et al.
Publicado: (2017)

Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant
por: Hikishima, Sadao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3pvisk6tuugoc70c5jdrf3tmn